Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody

Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody

Targets CD137 (4-1BB), a costimulatory molecule on activated T-cells. Urelumab enhances T-cell responses and is ideal for immune activation and cancer immunotherapy research.

$ 1.234.567,00 1234567.0 USD $ 1.234.567,00

$ 1.234.567,00

Diese Kombination existiert nicht.

In den Warenkorb

Geschäftsbedingungen
30-Tage-Geld-zurück-Garantie
Versand: 2-3 Geschäftstage